Company intelligence / Profile preview
CDA Research Group
Pittsburgh, Pennsylvania, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
CDA Research Group is a private U.S.-based biotech company focused on developing therapeutics for chronic pain, with its lead asset being 3-VM-1001, a topical cream evaluated in clinical trials for osteoarthritis-related knee pain. The most advanced trial was a Phase 1/2 double-blind, placebo-controlled study completed in recent years. No public data on pivotal or late-stage results are available as of June 2025.
- Therapeutic areas
- RheumatologyNeurology
- Modalities
- Small molecule
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
Not disclosed/publicly available information unavailable.
Beyond the preview
Go deeper on CDA Research Group.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CDA Research Group.